# Aura Biosciences, Inc.: filings

AURA · Nasdaq · CIK 1501796 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aura.md) · [Financials](/companies/aura/financials.md) · [Filings](/companies/aura/filings.md) · [Insiders](/companies/aura/insiders.md)

## Reports and events: 87 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 112, 8-K 52, 144 44, 3 24, 10-Q 15, SC 13G/A 12, D 11, SCHEDULE 13G/A 11, 424B5 8, S-8 8, CORRESP 7, DEFA14A 7, SC 13G 7, DEF 14A 6, SCHEDULE 13G 6, UPLOAD 6, 10-K 5, ARS 4, EFFECT 4, S-3 3, D/A 2, PRE 14A 2, SC 13D 2, SC 13D/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, S-1MEF 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 07:15 ET | [10-Q](/filings/0001193125-26-343429.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343429 |
| 2026-08-11 | 07:05 ET | [8-K](/filings/0001193125-26-343408.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-343408 |
| 2026-08-05 | 16:15 ET | [8-K](/filings/0001193125-26-335157.md) | 5.07 Shareholder vote results | 0001193125-26-335157 |
| 2026-07-08 | 07:17 ET | [8-K](/filings/0001193125-26-297992.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-297992 |
| 2026-06-29 | 17:28 ET | [DEF 14A](/filings/0001193125-26-288498.md) | Proxy statement, period 2026-08-05 | 0001193125-26-288498 |
| 2026-06-11 | 16:31 ET | [8-K](/filings/0001193125-26-267676.md) | 5.07 Shareholder vote results | 0001193125-26-267676 |
| 2026-05-11 | 16:15 ET | [10-Q](/filings/0001193125-26-216808.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216808 |
| 2026-05-11 | 16:15 ET | [SCHEDULE 13D/A](/filings/0000950142-26-001345.md) | Ownership report, active investor, amended | 0000950142-26-001345 |
| 2026-05-11 | 16:05 ET | [8-K](/filings/0001193125-26-216743.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216743 |
| 2026-05-05 | 17:21 ET | [8-K](/filings/0001193125-26-206804.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-206804 |
| 2026-05-04 | 16:20 ET | [8-K](/filings/0001193125-26-204049.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events | 0001193125-26-204049 |
| 2026-05-04 | 06:18 ET | [8-K](/filings/0001193125-26-202414.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202414 |
| 2026-04-20 | 16:05 ET | [DEF 14A](/filings/0001193125-26-163933.md) | Proxy statement, period 2026-06-11 | 0001193125-26-163933 |
| 2026-03-30 | 07:15 ET | [10-K](/filings/0001193125-26-130401.md) | Annual report, period 2025-12-31 | 0001193125-26-130401 |
| 2026-03-30 | 07:05 ET | [8-K](/filings/0001193125-26-130383.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-130383 |
| 2025-11-13 | 07:15 ET | [10-Q](/filings/0001193125-25-278817.md) | Quarterly report, period 2025-09-30 | 0001193125-25-278817 |
| 2025-11-13 | 07:05 ET | [8-K](/filings/0001193125-25-278810.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278810 |
| 2025-08-13 | 07:16 ET | [10-Q](/filings/0001193125-25-179426.md) | Quarterly report, period 2025-06-30 | 0001193125-25-179426 |
| 2025-08-13 | 07:05 ET | [8-K](/filings/0001193125-25-179418.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-179418 |
| 2025-06-18 | 16:06 ET | [8-K](/filings/0000950170-25-087885.md) | 5.07 Shareholder vote results | 0000950170-25-087885 |
| 2025-05-19 | 16:35 ET | [SCHEDULE 13D/A](/filings/0000902664-25-002479.md) | Ownership report, active investor, amended | 0000902664-25-002479 |
| 2025-05-16 | 16:05 ET | [8-K](/filings/0001193125-25-121677.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-121677 |
| 2025-05-15 | 06:05 ET | [10-Q](/filings/0000950170-25-071907.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071907 |
| 2025-05-15 | 06:02 ET | [8-K](/filings/0000950170-25-071839.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-071839 |
| 2025-04-24 | 16:15 ET | [DEF 14A](/filings/0000950170-25-058062.md) | Proxy statement, period 2025-06-17 | 0000950170-25-058062 |
| 2025-04-02 | 07:15 ET | [8-K](/filings/0000950170-25-048880.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-048880 |
| 2025-03-24 | 17:00 ET | [10-K](/filings/0000950170-25-043943.md) | Annual report, period 2024-12-31 | 0000950170-25-043943 |
| 2025-03-24 | 16:01 ET | [8-K](/filings/0000950170-25-043809.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-043809 |
| 2024-11-12 | 16:15 ET | [10-Q](/filings/0000950170-24-125428.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125428 |
| 2024-11-12 | 16:10 ET | [8-K](/filings/0000950170-24-125390.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-125390 |
| 2024-10-17 | 17:10 ET | [8-K](/filings/0001193125-24-238959.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-238959 |
| 2024-09-27 | 16:05 ET | [8-K](/filings/0001193125-24-227950.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-227950 |
| 2024-09-12 | 06:50 ET | [8-K](/filings/0001193125-24-217619.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217619 |
| 2024-08-08 | 07:10 ET | [10-Q](/filings/0000950170-24-093308.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093308 |
| 2024-08-08 | 07:05 ET | [8-K](/filings/0000950170-24-093298.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-093298 |
| 2024-06-21 | 16:07 ET | [8-K](/filings/0001193125-24-165656.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-165656 |
| 2024-06-14 | 16:37 ET | [10-K/A](/filings/0001193125-24-161680.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-161680 |
| 2024-06-04 | 17:07 ET | [8-K](/filings/0001193125-24-154364.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-154364 |
| 2024-05-09 | 07:10 ET | [10-Q](/filings/0000950170-24-056265.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056265 |
| 2024-05-09 | 07:05 ET | [8-K](/filings/0000950170-24-056252.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056252 |
| 2024-04-25 | 16:05 ET | [DEF 14A](/filings/0001193125-24-113878.md) | Proxy statement, period 2024-06-20 | 0001193125-24-113878 |
| 2024-04-15 | 16:07 ET | [8-K](/filings/0001193125-24-096204.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-096204 |
| 2024-03-27 | 07:11 ET | [10-K](/filings/0000950170-24-036814.md) | Annual report, period 2023-12-31 | 0000950170-24-036814 |
| 2024-03-27 | 07:05 ET | [8-K](/filings/0000950170-24-036811.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-036811 |
| 2024-01-08 | 07:31 ET | [8-K](/filings/0001193125-24-003887.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003887 |
| 2023-11-09 | 16:34 ET | [SC 13D/A](/filings/0000902664-23-005428.md) | Ownership report, active investor, amended | 0000902664-23-005428 |
| 2023-11-09 | 16:20 ET | [10-Q](/filings/0000950170-23-062097.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062097 |
| 2023-11-09 | 16:15 ET | [8-K](/filings/0000950170-23-062074.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062074 |
| 2023-11-06 | 16:01 ET | [8-K](/filings/0001193125-23-271351.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-271351 |
| 2023-10-02 | 16:11 ET | [8-K](/filings/0001193125-23-249055.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-249055 |

Page 1 of 2. [Older](/companies/aura/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.